This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTTsOLd1 #cardiology https://t.co/ArVJZVd3pN
Cardiovascular Safety of Testosterone-Replacement Therapy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Nov 2025Where it's discussed
-
News239 articles
-
X / Twitter220 posts
-
YouTube15 videos
-
Blogs10 articles
-
Facebook4 posts
-
Reddit2 posts
-
Bluesky1 posts
AI synopsis
What people are saying
The overall tone is supportive of the study's findings, with many posts emphasizing that TRT is safe for men's heart health, using words like 'important,' 'not to blame,' and 'noninferior.' Several examples, such as references to the NEJM study and personal anecdotes about being on TRT, reflect high interest and moderate engagement, indicating that this publication could potentially reshape attitudes and clinical approaches to testosterone therapy.
Most discussions support the study's conclusion that TRT does not increase cardiovascular risk, reflecting strong consensus.
The discussions demonstrate high curiosity and engagement with the topic, citing the NEJM study and highlighting its relevance for health decisions.
Many posts reference specific details like the TRAVERSE trial, showing moderate depth of engagement, with some sharing personal experiences and data.
The widespread sharing of the study and its findings suggests a significant influence on perceptions and clinical practices regarding TRT.
Abstract in brief
- The study investigated whether testosterone replacement therapy is safe for middle-aged and older men at risk of cardiovascular disease, comparing testosterone gel to a placebo over about 2 years.
- Results showed no significant increase in cardiovascular events with testosterone therapy, with similar rates of heart attacks, strokes, and death between the groups, indicating that testosterone does not worsen cardiovascular risk.
- Overall, the findings suggest that testosterone replacement therapy is likely safe from a cardiovascular perspective in men with hypogonadism at risk of heart disease.]
Top posts
Most liked on X and BlueskyHOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo: https://t.co/p1j5esIe9f https://t.co/elrAKBe08L https://t.co/0xoMBgmBzm https://t.co/0xoMBgmBzm https://t.co/jrNgiVUA7d -— Para entrar em contato com https://t.co/fC2t5WUyea
Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influence of (1) resistance exercise + nutrition +/- testosterone replacement on muscle mass post TAVR It was triaged for safety! Summary of this trial
Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial: Safety of Testosterone-Replacement Therapy in Older Men https://t.co/msQfKFKOKt https://t.co/1mYvOh71Rn
Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-the TRAVERSE study https://t.co/TVHLjeC3cW
All mentions
Effects and Safety of Testosterone Therapy in Men Over 65
Testosterone treatment in men over 65 with low levels improves desire, erectile function, and mood, with moderate benefits and no significant health risks in the short term, potentially offering a safe option for…
Assessing Cardiovascular Safety of Testosterone Replacement Therapy
This video discusses a study that investigated the safety of testosterone replacement therapy for middle-aged and older men at risk of cardiovascular disease. It found no significant increase in heart-related events…
Clarifying Testosterone Replacement Therapy Guidelines for Men with Hypogonadism
This video discusses the new guidelines for testosterone replacement therapy in men with hypogonadism, developed by the Society for Endocrinology, to address diagnostic and treatment uncertainties and improve patient…
Understanding the Impact of Testosterone on Longevity and Health
Lowering testosterone levels may increase longevity, as studies show eunuchs often live 14-19 years longer than noncastrated men. Testosterone supplements mainly aid sexual function and bone density; they do not enhance…
Assessing the Cardiovascular Safety of Testosterone Replacement Therapy
This discussion covers the pros and cons of TRT, including potential risks like atrial fibrillation, kidney injury, and blood pressure changes, based on recent studies. It explores different administration methods and…
Impact of Testosterone Replacement Therapy on Spermatogenesis in Men
Testosterone is essential for sperm production and sexual function. TRT can impair sperm production, requiring time to recover after stopping treatment. Medications like gonadotropins and aromatase inhibitors may help…
Testosterone Replacement Therapy and Heart Health Safety
When TRT is prescribed and monitored properly, studies show no increased risk of heart disease. The study compared testosterone gel to placebo over two years and found no significant rise in cardiovascular events…
Impact of Testosterone Therapy on Prostate Cancer and Cardiovascular Safety
In this episode, Dr. Brandon and Dr. Morgentaler discuss the longstanding belief that testosterone therapy increases prostate cancer risk and review recent studies showing no significant cardiovascular risks associated…
Cardiovascular Safety of Testosterone Replacement Therapy in Older Men
Testosterone replacement therapy appears safe for middle-aged and older men at cardiovascular risk, with no significant increase in heart attacks, strokes, or death observed over two years.
Testosterone Therapy for Erectile Dysfunction: Effectiveness and Insights
Dr. Morgentaler and Dr. Brandon discuss how testosterone can effectively treat erectile dysfunction in certain patients, challenging common guidelines. They analyze studies and share real-world patient stories…
Addressing the Black Box Warning on Vaginal Estrogen Therapy
Is one outdated warning label preventing women from receiving safe care? In this episode, Dr. Yahir Santiago-Lastra discusses the black box warning on vaginal estrogen, its historical context, and the need to update FDA…
Is Testosterone Replacement Therapy Safe for Heart Health? An Analysis
This episode examines whether testosterone therapy increases cardiovascular risk. The study comparing testosterone gel to placebo over two years found no significant rise in heart attacks, strokes, or death, suggesting…
Does Testosterone Increase Heart Attack Risk? Key Insights and Safety Tips
Recent studies explore the relationship between testosterone therapy and cardiovascular health. This video analyzes the latest evidence on whether TRT increases heart attack and stroke risks, offering guidance for safe…
Impact of Visceral Fat on Men's Health and Mortality Risks
Men with high visceral fat are at risk of diminished sexual potency due to the conversion of testosterone to estradiol. This condition not only affects sexual health but also increases the risk of cardiovascular issues…
Impact of Heart Failure Treatments and Colchicine on Cardiovascular Risks
This podcast discusses starting heart failure medications during hospitalization, along with insights on the Impella device. Recent data on colchicine's effectiveness in reducing cardiovascular events among chronic…
Impact of Visceral Fat on Men's Health and Mortality Risks
The presence of high visceral fat in men is linked to reduced sexual potency due to the conversion of testosterone into estradiol. This condition also increases cardiovascular risks and overall mortality, especially in…
@CoffeeBlackMD Not true: I discuss this with my patients all day based on this study. https://t.co/6LF5l4rlmy
@dants1202 @Mr_Hyde1866 Então, não: https://t.co/vJLtccWDeP https://t.co/LEihUcJrHG
https://t.co/Ap23LU1NRH
REFERENCES: 1: https://t.co/T3GYrovqhW 2: https://t.co/AQFFHJlyQU 3: https://t.co/T3GYrovqhW 4: https://t.co/lRXbvAyTfv 5: https://t.co/LYcVVroO9m 6: https://t.co/HAhK4J8spN The TRAVERSE study: https://t.co/NQ2xWD6WFU Bolt Health: https://t.co/uZXE5g0FIE
@cremieuxrecueil “The cardiovascular safety of testosterone-replacement therapy in middle-aged and older men with *hypogonadism* has not been determined.” There are probably plenty of people without hypogonadism taking steroids. Does data exist on that topic?
This is a good and informative trial, but it just wasn't big enough to rule out the slight risk elevation Epic observed with their very large-scale EHR data. Either way, I would not worry about an HR of 1.079 when TRT has so many other benefits. Source: https://t.co/fiMP5GNPbc
@cremieuxrecueil Here’s the link to the @NEJM article https://t.co/2HY96xMBYL
@cremieuxrecueil I don't see your source for cardiovascular disease risk. In fact, this study refutes those numbers. https://t.co/Fpj4829pBV
RT @AlessandroLoio2: Principais referências utilizadas para o vídeo sobre terapia de reposição de testosterona e ecocardiograma transtoráci…
Principais referências utilizadas para o vídeo sobre terapia de reposição de testosterona e ecocardiograma transtorácico com strain: https://t.co/Uu9zRSrVEa https://t.co/qLzBpUtRpG https://t.co/Y6W8z8Wthw https://t.co/LUPRmThSdP
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/48RsRsPqfD
Guys, good news: a new study says testosterone replacement therapy can seriously boost libido and sexual satisfaction if your T levels are low. Not a cure-all for ED, but it’s a solid win for hypogonadism & sexual health. Check it out: https://t.co/gC9N3JRDht #MensHealth #TRT"
@wordsinusername @AJA_Cortes https://t.co/AAXptnmEWM https://t.co/mt4XoincEp
@RhythmDoc01 Most of those concerns are dogma at this. You target symptoms. You have a lot to pay attention to. But it’s not poison. In much of medicine we have a huge confirmation bias because we only see bad. https://t.co/AAXptnmEWM https://t.co/mt4XoincEp https://t.co/OWuJIpnMaz
@21__Marcos___ @Epaminombasx @vitorvf9895 @arthurpinh3iro @pivetemaromba @WarlleyFelipe https://t.co/A5uRzmJeqw O estudo acerca de doses fisiológicas, vai ver que a maioria dos indicadores são neutros, mas tem alguns que apontam um leve desvio para o grupo que recebeu hormônio.
@21__Marcos___ @vitorvf9895 @Epaminombasx @arthurpinh3iro @pivetemaromba @WarlleyFelipe O estudo acerca de doses fisiológicas: Cardiovascular Safety of Testosterone-Replacement Therapy. Ele conclui que o uso de testo para reposição é seguro, mas alguns indicadores de incidência, principalmente de arritmia, é maior no grupo que toma hormônio.
#TRT no increased cardiovascular risk? #traversetrial 'In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events' pubmed.ncbi.nlm.nih.gov/37326322/
@knowclarified The most recent research suggests that it may even be protective: https://t.co/C64ydbjaAi I think the problems with earlier studies may have been too high of a dose. If kept in the physiological range, and key biomarkers are monitored, I don't think there's much evidence of any
Assesing Cardiovascular Safety of Testosterone Replacement Therapy for Male Hypogonadism: A Systematic Review and Meta Analysis Link article : https://t.co/LgZJyrkmr6 https://t.co/SWnknScpPv
Hormonalna terapia zastępcza testosteronem nie wiązała się z podwyższonym ryzykiem sercowo-naczyniowym. https://t.co/iEblIuQZ9L
@Bwhite4363 @9mm_smg I assume the cardiologist group has seen the TRAVERSE study that was released last year putting to rest a lot of the cardiovascular concerns? https://t.co/UxqeNpTScX
@PeterAttiaMD Data from the TRAVERSE trial: https://t.co/xO3QAOH5MP https://t.co/CEJOLgEfx9
RT @SMSNA_ORG: Check out the latest SMSNA TL;DR on "Cardiovascular Safety of Testosterone-Replacement Therapy" with @DrTomMasterson and @Dr…
RT @SMSNA_ORG: Check out the latest SMSNA TL;DR on "Cardiovascular Safety of Testosterone-Replacement Therapy" with @DrTomMasterson and @Dr…
Actually, I’m on TRT, but I guess I am that jacked that you think I’m on much more. Thank you. And my heart is healthier than yours, I guarantee it. And here’s some data: https://t.co/7AQDBTyziv Just assuming that you’re literate. Could be wrong. https://t.co/wd3ITe8Zvd
@Nbastang @throwaway7369 @elliotsteelcom Actually, I’m on TRT, but I guess I am that jacked that you think I’m on much more. Thank you. And my heart is healthier than yours, I guarantee it. And here’s some data: https://t.co/7AQDBTz783 Just assuming that you’re literate. Could be wrong.
RT @BowTiedLoon: Relatively small NEJM study (5246 patients) over a short peroid (33 months), but no statistical increase in incidence of p…
RT @BowTiedLoon: Relatively small NEJM study (5246 patients) over a short peroid (33 months), but no statistical increase in incidence of p…
Relatively small NEJM study (5246 patients) over a short peroid (33 months), but no statistical increase in incidence of prostate cancer with TRT over that time. https://t.co/fpNe7pgQk3 Based on what I have read, I'm not convinced that TRT that brings people into physiologic https://t.co/wxNl9sYyqW
RT @RogerKirby12: Cardiovascular safety of testosterone replacement therapy in men. Important and read @RogerKirby12 @TrendsMenHealth…
RT @SMSNA_ORG: Check out the latest SMSNA TL;DR on "Cardiovascular Safety of Testosterone-Replacement Therapy" with @DrTomMasterson and @Dr…
Check out the latest SMSNA TL;DR on "Cardiovascular Safety of Testosterone-Replacement Therapy" with @DrTomMasterson and @DrNannanT! Check out the full video: https://t.co/MKlWYfVFFM *Video represents opinions of speakers. https://t.co/DgHfNsMST1
Cardiovascular safety of testosterone replacement therapy in men. Important and read @RogerKirby12 @TrendsMenHealth https://t.co/91GTtZeIah
@gingers88193081 @hoovlet @TEDTalks @PamelaParesky @TEDchris A large clinical trial has demonstrated that replacing testosterone to physiological levels does not increase the risk of heart attacks or other cardiac events https://t.co/5EpktvJTwA
Lower risk of cardiovascular problems in men on testosterone replacement therapy (#trt) than those with low testosterone. Optimise your health Cardiovascular Safety of Testosterone-Replacement Therapy | New England Journal of Medicine https://t.co/tsN9Wgnonn
Segurança Cardiovascular da Terapia de Reposição de Testosterona #Cardiogeriatria #Geriatria #Longevidade #Endócrinogeriatria #Antiaging https://t.co/VPQASbBCdd
Really interesting study showing that Testosterone Replacement Therapy is actually not to blame for an increase in cardiovascular disease amongst and could be a possible avenue for practitioners to consider. @invinceible24 #PSUClinExPhy https://t.co/dk65ZGNHWC
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/pylQHKJks9
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/pylQHKJks9
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @Paul_Wischmeyer:
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @Paul_Wischmeyer:
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
RT @AlessandroLoio2: HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo…
HOMEM: você sabia que manter bons níveis de testosterona MELHORA sua saúde cardiovascular? —— Referências deste vídeo: https://t.co/p1j5esIe9f https://t.co/elrAKBe08L https://t.co/0xoMBgmBzm https://t.co/0xoMBgmBzm https://t.co/jrNgiVUA7d -— Para entrar em contato com https://t.co/fC2t5WUyea
RT @jpcostabel: https://t.co/AA2jLiLR55
From the AMMG E-Journal, Cardiovascular Safety of Testosterone Replacement Therapy: https://t.co/ilvZhqLasu #CardiovascularSafetyOfTestosterone #AMMG #AgeManagementMedicine #CMEEducation #ContinuingMedicalEducation #CMEConferences https://t.co/GHJZcxLVBC
RT @jpcostabel: https://t.co/AA2jLiLR55
https://t.co/AA2jLiLR55
RT @drhungo: Testosterone therapy in
Testosterone therapy in
@dockevinmcleod
RT @JimDwyerMD: Notable Cardiology Articles of 2023 - Clopidogrel After Coronary Stenting
Notable Cardiology Articles of 2023 - Clopidogrel After Coronary Stenting
RT @SeeFisch: This one is still hard for me to take and agree with even though it is so clear. Cardiovascular Safety of Testosterone-Repl…
This one is still hard for me to take and agree with even though it is so clear. Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/gLBVdM2TSx
A recent NEJM study showed that TRT in those with low testosterone DID NOT have negative cardiovascular
RT @FITrebelde: Nuevo estudio: Las terapias de reemplazo hormonal no elevan el riesgo cardiovascular en hombres https://t.co/AmTXlDPHni
RT @FITrebelde: Nuevo estudio: Las terapias de reemplazo hormonal no elevan el riesgo cardiovascular en hombres https://t.co/AmTXlDPHni
Nuevo estudio: Las terapias de reemplazo hormonal no elevan el riesgo cardiovascular en hombres https://t.co/AmTXlDPHni
RT @ACCinTouch: Testosterone is widely prescribed to aging men but there have been concerns about ❤️ safety. In this #ACCEL Lite intervie…
RT @ACCinTouch: Testosterone is widely prescribed to aging men but there have been concerns about ❤️ safety. In this #ACCEL Lite intervie…
Testosterone is widely prescribed to aging men but there have been concerns about ❤️ safety. In this #ACCEL Lite interview, Drs. Steven E. Nissen and William E. Boden discuss Cardiovascular Safety of Testosterone-Replacement Therapy. Tune in here: https://t.co/f9NKjhgmja https://t.co/LgImbidN3V
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/E4snwlS1WZ
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/O78FWT4Rzz
https://t.co/ZiJM1Gy59S
Testosterone Therapy Did Not Increase Major Cardiovascular Events https://t.co/eMoNa5c8Ma
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
RT @NEJM: This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTT…
This week’s most cited articles: 1. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients https://t.co/V3FTTsOLd1 #cardiology https://t.co/ArVJZVd3pN
Cardiovascular Safety of Testosterone-Replacement Therapy #science #publication #research #publications https://t.co/E5QDGVC0gv
RT @geri_doc: Good Grief! More ageist research in the NEJM RCT Cardiovascular safety of testosterone replacement RX in "middle age and old…
RT @geri_doc: Good Grief! More ageist research in the NEJM RCT Cardiovascular safety of testosterone replacement RX in "middle age and old…
RT @geri_doc: Good Grief! More ageist research in the NEJM RCT Cardiovascular safety of testosterone replacement RX in "middle age and old…
RT @geri_doc: Good Grief! More ageist research in the NEJM RCT Cardiovascular safety of testosterone replacement RX in "middle age and old…
RT @geri_doc: Good Grief! More ageist research in the NEJM RCT Cardiovascular safety of testosterone replacement RX in "middle age and old…
Good Grief! More ageist research in the NEJM RCT Cardiovascular safety of testosterone replacement RX in "middle age and older men" excludes men over age 80. No justification. Blatant Ageism. This really needs to stop. How did this get through CHR? https://t.co/uuAKhZ775k
@CakeNutrition @RoseAndGarden I havent seen evidence that low dose T has any appreciable CVD risk see NEJM trial https://t.co/ZkVJQaAhAH
RT @DrMohitKhera: Huge day for testosterone research today! The results of the TRAVERSE Trial, the largest randomized placebo-controlled tr…
RT @ChrisPalmerMD: Middle-aged men with low testosterone... Is TRT safe for your heart? This study suggests yes. (this doesn't apply…
The use of testosterone among eligible men aged 45-80 for 2 years was not found to increase the risk of cardiovascular disease compared to placebo. @LincoffMichael @NEJM https://t.co/NAck1YDyZC
Cardiovascular Safety of Testosterone-Replacement Therapy. | Read by QxMD https://t.co/cGFLys3Evf
Testosterone-Replacement Therapy Is Safe for Cardiovascular Health, According to New Study #TRT #MensHealth #hearthealth #testosterone #longevity Read the Traverse Study https://t.co/8GNPWugeJR
Cardiovascular safety of testosterone-replacement therapy update In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, the trial enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who reported
Testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events https://t.co/Bu8XNKYW5I
Atrial fibrillation: 3.5% vs. 2.3% Acute kidney injury: 2.3% vs. 1.5% Pulmonary embolism: 0.9% vs. 0.5% Original study Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy(TRT). N Engl J Med, 2023. doi: 10.1056/NEJMoa2215025
RT @SeeFisch: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/gLBVdM2TSx
Popular 'low T' treatment is safe for men with heart disease, but doctors warn it's no youth serum https://t.co/XDn7bUYfsM https://t.co/9QF5YHAV3x https://t.co/MDzfsh824l
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/gLBVdM2TSx
RT @agingdoc1: Cardiovascular Safety of Testosterone-Replacement Therapy
RT @dramitkhera: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM Impoartant study that has been long awaited. Helps cla…
RT @docwas: Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/lhqkWIZmQx
RT @NEJM: Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial:…
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/7pUqIg9zuP #assignmentwriting #thesisandproject #pgthesis #medicalthesis #medicalpgaspirants #medicine https://t.co/7AAVQ7U5lP
RT @agingdoc1: Cardiovascular Safety of Testosterone-Replacement Therapy
RT @agingdoc1: Cardiovascular Safety of Testosterone-Replacement Therapy
Cardiovascular Safety of Testosterone-Replacement Therapy
RT @docwas: Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/lhqkWIZmQx
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/lhqkWIZmQx
男性更年期に対するテストステロン補充は、心血管イベントを増やさない ただし、追跡期間は平均33ヶ月 PSAは上昇するが、前立腺癌の発生も変わらず Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/JNUrnf94sv
RT @NEJM: Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial:…
RT @NEJM: Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial:…
RT @NEJM: Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial:…
RT @vic_pallares: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM
RT @NEJM: Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial:…
Original Article: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE study) https://t.co/V3FTTsOLd1 Editorial: Safety of Testosterone-Replacement Therapy in Older Men https://t.co/msQfKFKOKt https://t.co/1mYvOh71Rn
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/l7WDFA1N31
(238/347) #論文マラソン テストステロン補充は心イベントを増やすか 多施設共同無作為化二重盲検プラセボ対照非劣性試験 心血管疾患の既往またはリスクが高く、性腺機能低下症の患者にテストステロンを投与 33ヶ月追跡。 テストステロンで心イベントは増えず。 https://t.co/XZZYiDXwc6
RT @vic_pallares: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events.
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
RT @vic_pallares: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/MxLvMk45Ka
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM - Bravo @LincoffMichael
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
RT @DanielJDrucker: Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-t…
Cardiovascular safety of testosterone replacement therapy in men age 45-80 with biochemical and clinical hypogonadism-the TRAVERSE study https://t.co/TVHLjeC3cW
#Cardiovascular Safety of Testosterone-Replacement Therapy For More: https://t.co/w1wVNQt7MZ
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/SDxdVorLgJ
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/s3znZ3nTkG
RT @EARL_med_tw: 心血管疾患既往または高リスクの性腺機能低下症男性において,テストステロン補充療法は主要心血管イベントの発生率に関してプラセボに対し非劣性.5246例DB-RCT,TRAVERSE study(N Engl J Med 2023 Jun.16)…
RT @EARL_med_tw: 心血管疾患既往または高リスクの性腺機能低下症男性において,テストステロン補充療法は主要心血管イベントの発生率に関してプラセボに対し非劣性.5246例DB-RCT,TRAVERSE study(N Engl J Med 2023 Jun.16)…
心血管疾患既往または高リスクの性腺機能低下症男性において,テストステロン補充療法は主要心血管イベントの発生率に関してプラセボに対し非劣性.5246例DB-RCT,TRAVERSE study(N Engl J Med 2023 Jun.16) https://t.co/keP5WSZsse
RT @AAlMohammad87: An interesting and important paper @NEJM showed that testosterone given for 21/12 and FU for 33/12 to men with testoster…
@kevinnbass https://t.co/KmJqA9AzAE
An interesting and important paper @NEJM showed that testosterone given for 21/12 and FU for 33/12 to men with testosterone <300 ng/dL with established or high CV risk, is non-inferior to placebo in incidence of major MACE https://t.co/V2OmDfAujT
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/HfZ0kyOhBq
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/qEttJ31dxr
Cardiovascular Safety of Testosterone-Replacement Therapy | comment: Steven E. Nissen MD, MACC https://t.co/RUSK2iHrPT via @practiceupdate
RT @ALEX_MISCHIE: Cardiovascular Safety of Testosterone-Replacement Therapy @NEJM https://t.co/03es2OYlPK
Cardiovascular Safety of Testosterone-Replacement Therapy @NEJM https://t.co/03es2OYlPK
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @EndocrinoLaPaz: Cardiovascular Safety of Testosterone-Replacement Therapy ☝️| NEJM https://t.co/oXVpZi6yWu
Cardiovascular Safety of Testosterone-Replacement Therapy ☝️| NEJM https://t.co/oXVpZi6yWu
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
RT @DrDamluji: Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influ…
Cardiovascular Safety of Testosterone-Replacement Therapy: @NEJM I wrote R21 to @NIHAging that aimed to evaluate the influence of (1) resistance exercise + nutrition +/- testosterone replacement on muscle mass post TAVR It was triaged for safety! Summary of this trial
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/YA2EKqrcj6
RT @moreno_perez_o: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/Ja6EgPIK1K @sociedadSEEN @fjavesc @esteba…
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/mxji7Qo69y
RT @moreno_perez_o: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/Ja6EgPIK1K @sociedadSEEN @fjavesc @esteba…
RT @dramitkhera: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM Impoartant study that has been long awaited. Helps cla…
Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM https://t.co/FbaxnlPNsg
RT @dramitkhera: Cardiovascular Safety of Testosterone-Replacement Therapy | NEJM Impoartant study that has been long awaited. Helps cla…
Cardiovascular Safety of Testosterone-Replacement Therapy @NEJM https://t.co/9RdOouFWcj
Via #ENDO2023 @NEJM ✅ TRAVERSE study
RT @agingdoc1: Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/HGrSb1NjoQ @NEJM https://t.co/msUtYZsKpi
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/HGrSb1NjoQ @NEJM https://t.co/msUtYZsKpi
Cardiovascular Safety of Testosterone-Replacement Therapy https://t.co/Fe5CxB961u https://t.co/tuBhLOK51l
RT @medical_xpress: Popular 'low T' treatment is safe for #men with #heartdisease, but doctors warn it's no youth serum @nejm https://t.co/…
Popular 'low T' treatment is safe for #men with #heartdisease, but doctors warn it's no youth serum @nejm https://t.co/T0NAsJhKmg https://t.co/O0d26uewWK
SP
BM
ML
D